[Skip to Content]
[Skip to Content Landing]

Catheter Ablation vs Drug Therapy for Patients With Atrial Fibrillation: The CABANA Trial

Two reports in JAMA detail findings from the CABANA trial, a randomized, open-label trial comparing the effects of drug therapy vs cardiac catheter ablation on a composite outcome of death, disabling stroke, serious bleeding, or cardiac arrest in patients with symptomatic atrial fibrillation. In this video, JAMA Deputy Editor Gregory Curfman, MD, describes the study and the clinical implications of the results.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close